Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRISTAL trial of aspirin versus enoxaparin for venous thromboembolism prophylaxis after hip or knee arthroplasty
ACTRN12618001879257Phase 4Terminated
- Sponsor
- University of New South Wales
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in venous thromboembolism (VTE) comparing Aspirin prophylaxis with Enoxaparin prophylaxis (2 arms). Started Apr 2019; status: terminated.
02
Drugs
aspirinenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ACTRN12618001879257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001879257.